1. As to the Plaintiff A’s KRW 45,714,280, Plaintiff C, and D respectively, KRW 9,142,850 and KRW 9,142,850 and each of the said money.

1.The actual amount of the insurance coverage (compensation) - The actual amount of cancer diagnosis costs - The actual amount of cancer insurance coverage (the payment of KRW 2 million for the upper cancer, the other fee, and the boundary-type cancer) after the date of commencement of coverage - The actual amount of cancer diagnosis costs of KRW 5 million (1 million for the upper cancer, the other fee, and the boundary-type cancer after the date of commencement of coverage) shall be added to cancer diagnosis costs - The actual amount of cancer diagnosis costs after the date of commencement of coverage - The actual amount of cancer diagnosis costs of cancer (excluding the upper cancer, the other fee, and the boundary-type cancer) shall be paid at the time of cancer diagnosis after the date of commencement of coverage - The amount of the insurance coverage amount of KRW 20 million,000,000,000,000,000,000 won when a cause for payment prescribed by the terms and conditions occurs after the date of commencement of coverage.

A. On October 12, 2016, B and Plaintiff A entered into an insurance contract with the Defendant for Non-Distribution ScI (hereinafter “each of the instant insurance contracts”) as the insured respectively, and among them, the subscription security (the content of compensation) and the amount of the insurance coverage associated with the instant case are as follows:

8. Article 5 (Examination and Confirmation of the definitions of the upper and upper cancer, other skin cancer, and boundaryal species) of the General Terms and Conditions for Cancer Examination (1) The term " Cancer" in this Agreement means any disease classified as malicious life in the fourth Korean Standard Disease Death Classification.

3. We mean that I will see the table of malicious life classification. (4) In this contract, the term "dietal species" means the table of the fourth Korean Standard Disease Classification (attached Table).

5. 행동양식 불명 또는 미상의 신생물 분류표 참조)에서 정한 질병을 말합니다. ⑤ 암 및 상피내암, 기타피부암, 경계성종양의 진단확정은 해부병리 또는 임상병리의 전문의사 자격증을 가진 자에 의하여 내려져야 하며, 이 진단은 조직(fixed tissue), 미세침흡인검사(fine needle aspiration biopsy) 또는 혈액검사(hemic system)에 대한 현미경 소견을 기초로 하여야 합니다. 19. 치명적 질병진단비 특별약관 제4조(치명적 질병의...